For citations:
Lila A.M., Mazurov V.I., Zonova E.V., Nesmeyanova O.B., Plaksina T.V., Krechikova D.G., Reshet’ko O.V., Denisov L.N., Gordeev I.G., Pokrovskaya T.G., Antipova O.V., Kropotina T.V., Povarova T.V., Shesternya P.A., Ushakova E.N., Soroka N.F., Kunder E.V., Eremeeva A.V., Chernyaeva E.V., Ivanov R.A., Pukhtinskaya P.S. COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE-BLIND PHASE III CLINICAL STUDY ASART-2. Rheumatology Science and Practice. 2018;56(3):293-301. (In Russ.) https://doi.org/10.14412/1995-4484-2018-293-301
Email this article 